$93.53

-0.67 (-0.71%)

After Hours: $93.15 (-0.38, -0.41%)

Weekly Expected Move ±3.7%

$86 $90 $93 $97 $100

NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Buy · Power 76 · $5.6B mcap · 58M float · 1.36% daily turnover · Short 58% of daily vol

Credit Risk of going bust: lower than 81% of companies Debt: 12.7% of company value Bonds: $91.0M held by 33 funds → details ▾

Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.81 (down 99.1%), Merit Medical Systems, Inc. would be worth roughly what it owes.
Total debt $820.1M against a stock market value of $5.62B.
Distance to default 10.02 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $368.1M (short-term plus half of long-term), stock volatility 29.6%; Altman Z 4.46. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$1.5B +11.8% ▲

5Y CAGR: +9.5%

Gross Profit

$738M +14.8% ▲

5Y CAGR: +13.0%

Operating Income

$185M +18.6% ▲

Net Income

$128M +6.8% ▲

EPS (Diluted)

$2.13 +4.9% ▲

EBITDA

$332M +21.2% ▲

5Y CAGR: +26.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.1B	$1.2B	$1.3B	$1.4B	$1.5B
YoY Growth	+11.5%	+7.1%	+9.2%	+7.9%	+11.8%
Cost of Revenue	$589M	$632M	$673M	$713M	$778M
Gross Profit	$485M	$519M	$584M	$643M	$738M
Gross Margin	45.2%	45.1%	46.4%	47.4%	48.7%
R&D Expenses	$71M	$76M	$83M	$84M	$97M
SG&A Expenses	$336M	$343M	$374M	$377M	$455M
Operating Expenses	$424M	$432M	$459M	$488M	$554M
Operating Income	$61M	$88M	$124M	$156M	$185M
Operating Margin	5.7%	7.6%	9.9%	11.5%	12.2%
Interest Expense	$5M	$6M	$16M	$31M	$26M
Income Before Tax	$54M	$83M	$112M	$150M	$171M
Tax Expense	$5M	$8M	$18M	$30M	$42M
Net Income	$48M	$75M	$94M	$120M	$128M
Net Margin	4.5%	6.5%	7.5%	8.9%	8.5%
EPS (Diluted)	$0.84	$1.29	$1.62	$2.03	$2.13
EBITDA	$155M	$181M	$229M	$274M	$332M
Shares Outstanding	57M	58M	58M	59M	60M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$340M	$355M	$355M	$382M	$384M	$394M	$382M	$419M
Cost of Revenue	$182M	$182M	$183M	$198M	$198M	$199M	$197M	$204M
Gross Profit	$158M	$173M	$172M	$184M	$186M	$195M	$185M	$215M
Gross Margin	46.4%	48.7%	48.4%	48.2%	48.5%	49.6%	48.4%	51.4%
R&D Expenses	$21M	$25M	$22M	$24M	$24M	$27M	$23M	$25M
SG&A Expenses	$100M	$108M	$107M	$113M	$120M	$115M	$118M	$129M
Operating Expenses	$120M	$136M	$131M	$138M	$144M	$141M	$141M	$155M
Operating Income	$37M	$37M	$41M	$47M	$43M	$54M	$44M	$61M
Operating Margin	11.0%	10.3%	11.5%	12.3%	11.1%	13.7%	11.5%	14.5%
Interest Expense	$8M	$8M	$7M	$7M	$7M	$6M	$7M	$12M
Income Before Tax	$37M	$33M	$38M	$43M	$39M	$51M	$54M	$51M
Tax Expense	$8M	$5M	$8M	$11M	$11M	$13M	$13M	$13M
Net Income	$28M	$28M	$30M	$33M	$28M	$38M	$41M	$39M
Net Margin	8.4%	7.9%	8.5%	8.5%	7.2%	9.6%	10.7%	9.3%
EPS (Diluted)	$0.48	$0.46	$0.49	$0.54	$0.46	$0.63	$0.68	$0.65
EBITDA	$74M	$73M	$77M	$84M	$80M	$92M	$93M	$97M
Shares Outstanding	60M	61M	61M	61M	60M	60M	60M	60M

MMSI NASDAQ